PartnershipUpdated on 10 November 2025
BIOTECH: Finding funding to develop Novel Neuropsychiatric Drugs via Computational Multi-Target Drug Design
Founder & CEO at ReSynapse Therapeutics
Nes Ziona, Israel
About
We would like to find potential strategic partnership for funding a co-development of Novel Neuropsychiatric Drugs via Computational Multi-Target Drug Design, aiming for treatment-resistant depression patients.
Similar opportunities
Partnership
BIOTECH: Finding a strategic partner to develop novel psychitric drugs
Dorit Cohen
Founder & CEO at ReSynapse Therapeutics
Nes Ziona, Israel
Project cooperation
- Early
- Research
- Technical
Precious Kilimo
Strategy/Finance at Calla Lily Clinical Care
London, United Kingdom
Project cooperation
BIOTECH: Finding a psychicatric pharmacology preclinical lab
- Planning
- Research
- Technical
- Financing
Dorit Cohen
Founder & CEO at ReSynapse Therapeutics
Nes Ziona, Israel